Executives at biotechnology firm Genzyme are debating funding a clinical trial for a new version of a medical device called Synvisc. The trial is expensive and the odds of success are not high, but the upside is substantial. The case presents a common business question: invest or not? The case forces students to wrestle with a number of complex issues and analyze the financials of their decisions.

【書誌情報】

ページ数：15ページ

サイズ：A4

商品番号：HBSP-KEL439

発行日：2010/1/26

登録日：2014/9/19